The short answer
Bitter melon has not been shown to cause extra hypoglycemia with regular human insulin in the reviewed evidence. Human findings vary, and a supplement should not replace the insulin plan.
What this answer covers
Momordica charantia oral capsule evidence; food, juice, seed and concentrated extracts differ.
- Supplement or preparation
- Momordica charantia
- Medication ingredient
- insulin, regular, human
The controlled trial was not clearly positive
A small placebo-controlled trial on standard diabetes therapy found no significant HbA1c or fasting-glucose benefit from bitter-melon capsules. This challenges the assumption that every preparation substantially lowers glucose.
The insulin identity was not established
The inspected abstract does not identify a regular-human-insulin subgroup or a rate of hypoglycemia during regular insulin co-use. General diabetes treatment is not enough to establish a particular drug interaction.
Check preparation rather than relying on the name
The tested capsules do not represent all juices, foods or extracts. Different amounts and plant parts may produce different exposure; neither a negative trial nor traditional use establishes universal safety.
Review unexpected readings
Discuss the exact product and dose with the diabetes team before starting or stopping it. Follow your agreed glucose-monitoring and low-glucose treatment plan; do not adjust insulin on your own. Keep the labeled insulin meal instructions and do not use a supplement to substitute for insulin.
Evidence and practical considerations
Side effects & toxicity
Indirect preparation-specific clinical evidence does not establish added hypoglycemia with regular human insulin.
- Exact scope
- Momordica charantia oral capsule evidence; food, juice, seed and concentrated extracts differ. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 40adults with type2diabetes.
No significant improvement in HbA1c or fasting glucose with bitter-melon capsules versus placebo on standard therapy.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Small trial; abstract does not identify regular-human-insulin exposure or establish an exact-pair hypoglycemia rate.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact regular-insulin article with route, concentration and clinical endpoint boundaries. | |
| Research summary published |
Article revision: 0e92a06bd12ce8ac
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.